bioMerieux gets busy, with its sights set on more products, bigger markets in the next millennium
This article was originally published in Clinica
It has been a busy year for bioMerieux. The French company increased its research and development spending to cope with a number of new products currently in the pipeline. It opened five subsidiaries or liaison offices in South America and Asia and it also extended the range of tests for its automated EIA analyser, the Vidas system. bioMerieux says there are 10,000 Vidas units installed worldwide.